SSY GROUP (02005): Acetylaminophenol tablets approved by the National Medical Products Administration for new 0.5g specification.
Sinopharm Group (02005) announced that the group's paracetamol tablets have been approved by the China National Medical Products Administration...
SSY GROUP (02005) announced that the group's paracetamol tablets have been approved by the National Medical Products Administration of China (NMPA) for a new 0.5g specification, and both the 0.3g and 0.5g paracetamol tablets have been approved by the NMPA for generic drug quality and therapeutic efficacy consistency evaluation.
Paracetamol tablets are mainly used for fever caused by common cold or influenza, and also used to relieve mild to moderate pain.
Related Articles
Asset Allocation Outlook for July: Go with the flow and prepare for change
Tracking the concept of Hong Kong stocks | The biggest impact of tariff uncertainty has dissipated, institutions are optimistic about the continued rise in copper prices (with concept stocks)
Hong Kong stock market concept tracking | Ministry of Industry and Information Technology governs the photovoltaic industry's low-price disorderly competition. Silicon wafer prices are expected to bottom out (with concept stocks attached)
Asset Allocation Outlook for July: Go with the flow and prepare for change
Tracking the concept of Hong Kong stocks | The biggest impact of tariff uncertainty has dissipated, institutions are optimistic about the continued rise in copper prices (with concept stocks)
Hong Kong stock market concept tracking | Ministry of Industry and Information Technology governs the photovoltaic industry's low-price disorderly competition. Silicon wafer prices are expected to bottom out (with concept stocks attached)
